Viking Therapeutics
(NASDAQ:VKTX)
$64.75
-1.72[-2.59%]
At close: Apr 18
$64.75
0[0.00%]
After Hours: 7:31PM EDT
Q1 2024 Earnings in 6 days from now on Wed Apr 24th, after the market close
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Viking Therapeutics Stock (NASDAQ:VKTX), Quotes and News Summary

Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.

Open$66.130
Close$64.670
Volume / Avg.2.406M / 6.378M
Day Range64.500 - 66.250
52 Wk Range8.280 - 99.410
Market Cap$7.137B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
44
Short Interest
11.65%
Days to Cover1.65

Recent News

Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
Wall Street is set to break a two-day losing streak on Tuesday, as major indices trended positively during midday trading in New York. The S&P 500 saw a modest uptick of 0.3% for the day, with the Dow Jones Industrial Average, the Nasdaq 100 and the Russell 2000 experiencing a 0.2% surge.
Piero Cingari
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Avi Kapoor
Viking Therapeutics' Investigational Oral Obesity Drug Shows Reduced Weight In Small Study
Explore Viking Therapeutics' Phase 1 MAD trial results for oral VK2735, a promising treatment for metabolic disorders like obesity. Dose-dependent reductions in body weight, encouraging safety/tolerability data, and plans for Phase 2 trial revealed.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
6
Feb
10
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Viking Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of bio...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VKTX
LEGN

FAQ

Q

How do I buy Viking Therapeutics (VKTX) stock?

A

You can purchase shares of Viking Therapeutics (NASDAQ: VKTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Viking Therapeutics's (VKTX) competitors?

A

Other companies in Viking Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for Viking Therapeutics (VKTX) stock?

A

The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Oppenheimer on Wednesday, March 27, 2024. The analyst firm set a price target for 138.00 expecting VKTX to rise to within 12 months (a possible 113.13% upside). 31 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Viking Therapeutics (VKTX)?

A

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $64.75 last updated April 18, 2024 at 7:31 PM EDT.

Q

Does Viking Therapeutics (VKTX) pay a dividend?

A

There are no upcoming dividends for Viking Therapeutics.

Q

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

A

Viking Therapeutics’s Q1 earnings are confirmed for Wednesday, April 24, 2024.

Q

Is Viking Therapeutics (VKTX) going to split?

A

There is no upcoming split for Viking Therapeutics.

Q

What sector and industry does Viking Therapeutics (VKTX) operate in?

A

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch